Marine sponges of the order Verongida are characterized by their ability to synthesize brominated tyrosine derivatives, many of which possess potent anti-microbial and cytotoxic activities. 1 Purealin, [2] [3] [4] Lipopurealin A-E, 5, 6 Purealidin A-S, 6-11 Psammaplysin A-B, 12 Purpuramine A-J, 11,13 Aplysamines 2-5 14 and Macrocyclic peptides Bastadins 15 isolated from Verongida have been previously reported as brominated tyrosine derivatives. The diverse modification of these biosynthetically related compounds occurs in both the side chain and aromatic ring of the brominated tyrosine precursors. It has been reported that many brominated tyrosine derivatives were isolated from Verongida, Psammaplysilla purpurea; 1,2,5-10,13-15 therefore, P. purpurea is a potential resource for the chemical screening of novel compounds. We thus attempted to isolate new compounds from P. purpurea, and resulted in the isolation of a new compound designated as JBIR-44 (1) (Figure 1) . In this paper, we report the isolation, structure elucidation and brief biological activity of 1.
C (2.1 mg), 6 purpuramine F (1.8 mg), 13 araplysillin I (45.3 mg) 16 and aplysamine 4 (175 mg). 14 Compound 1 was obtained as a colorless oil (UV (MeOH) l max (e) 283 (1700), 208 (17 600)). The electrospray ionization-mass spectrum (ESI-MS) displayed an isotopic cluster (640.9, 642.9, 644.9, 646.9, 648.9) that was consistent with the presence of four bromine atoms. Its molecular formula was established as C 18 H 16 The structure of 1 was elucidated as follows: The 1 H and 13 C NMR spectral data for 1 are shown in Table 1 and to an aromatic quaternary carbon C-6 (d C 137.3). Thus, the methylene carbon C-7 was deduced to be substituted at the position of C-6. The all assignment of this tetrasubstituted benzene ring moiety was established by 1 H-13 C long-range couplings as shown in Figure 2 . These results revealed the presence of a 2,4-disubstituted-3-methoxyphenylene moiety as shown in Figure 2 . In the same manner, long-range couplings observed in the HMBC spectrum and the 13 C chemical shift at C-15 (d C 150.7) revealed a 4-oxygenated 1,3,4,5-tetrasubstituted benzene moiety. A methylene proton 11-H (d H 2.73), which was spin coupled to a methylene proton 10-H (d H 3.45), was 1 H-13 C long-range coupled to aromatic methine carbons C-13/17 (d C 133.6) and to an aromatic quaternary carbon C-12 (d C 134.6). 1 H-13 C long-range couplings from the methylene proton 10-H to an amide carbonyl carbon C-9 (d C 165.4), from the methylene proton 7-H to a hydroxyimino carbon C-8 (d C 153.8) and to the amide carbonyl carbon C-9, together with IR absorptions assignable to an amide and an imino functional group (1655 and 1620 cm À1 , respectively) 11 revealed that two tetrasubstituted benzene substructures were connected through a 2-(hydroxyimino) acetamide moiety 11 as shown in Figure 2 . This structure was also supported by the 13 C chemical shifts of the amide and imino carbons and IR absorptions observed in aplysamine 4. 14 From the molecular formula of 1, four bromine atoms were determined to be substituted at the position of C-2, C-4, C-14 and C-16, and a remaining hydroxyl group was assigned to an oxime functional group at the imino moiety. The geometry of C-8 at oxime moiety was elucidated as E from the up-field 13 17 of which positions corresponded to C-7 in 1, supported the stereochemistry at C-8.
The cytotoxic effects of 1 and aplysamine 4 against human cervical carcinoma HeLa cells were determined by WST-8 colorimetric assay (Dojindo, Kumamoto, Japan). HeLa cells were treated for 48 h with various concentrations of 1 and aplysamine 4, which showed the cytotoxic effects in a dose-dependent manner with the IC 50 values of 3.7 and 3.4 mM, respectively. These results indicate that a 3-aminopropanol chain structure at C-15 does not affect cytotoxic activity. As 1 is a structurally interesting compound, it is expected to be a potential candidate for a novel anti-cancer drug targeting new molecules. Studies on detailed biological activities are now underway. JBIR-44, a new bromotyrosine compound T Fujiwara et al
